Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Myomo ( (MYO) ).
Myomo, a wearable medical robotics company specializing in the MyoPro upper-limb orthosis for patients with neurological disorders and paralysis, is based in Burlington, Massachusetts and serves U.S. and international markets through its sales and clinical network. Its technology uniquely uses non-invasive EMG sensors to restore functional arm movement for activities of daily living.
On May 9, 2026, Myomo appointed Joseph M. “Joe” Manko Jr., senior principal of major shareholder Horton Capital Management, to its board of directors as a Class I director, a move announced publicly on May 13, 2026. His extensive background in investment banking, asset management and medtech board service is expected to bolster Myomo’s capital markets expertise and governance as the company pursues its growth strategy and efforts to drive long-term shareholder value.
The most recent analyst rating on (MYO) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Myomo stock, see the MYO Stock Forecast page.
Spark’s Take on MYO Stock
According to Spark, TipRanks’ AI Analyst, MYO is a Neutral.
The score is held down primarily by weak financial performance (persistent losses, heavy cash burn, and higher leverage). Offsetting this, the latest earnings call indicates improving operating trends and disciplined expense growth targets, while technicals are neutral and valuation support is limited due to negative earnings and no dividend.
To see Spark’s full report on MYO stock, click here.
More about Myomo
Myomo, Inc. is a wearable medical robotics company that develops and markets the MyoPro powered upper-limb orthosis to improve arm and hand function for individuals with neurological disorders and upper-limb paralysis. Headquartered in Burlington, Massachusetts, it focuses on enabling patients to perform daily activities, return to work, live independently and reduce care costs in the U.S. and international markets.
Average Trading Volume: 366,348
Technical Sentiment Signal: Sell
Current Market Cap: $30.07M
For a thorough assessment of MYO stock, go to TipRanks’ Stock Analysis page.